Published in Blood on August 15, 1994
Coinfection with HIV-1 and HCV--a one-two punch. Gastroenterology (2009) 1.78
Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported Outcomes. J Infect Dis (2015) 1.56
Virome Analysis of Transfusion Recipients Reveals a Novel Human Virus That Shares Genomic Features with Hepaciviruses and Pegiviruses. MBio (2015) 1.55
Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users. Eur J Epidemiol (2007) 1.52
Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients. Gut (2003) 1.48
Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes. J Virol (2009) 1.41
Modulation of HCV replication after combination antiretroviral therapy in HCV/HIV co-infected patients. Sci Transl Med (2014) 1.39
Female sex and IL28B, a synergism for spontaneous viral clearance in hepatitis C virus (HCV) seroconverters from a community-based cohort. PLoS One (2011) 1.38
HCV RNA levels in a multiethnic cohort of injection drug users: human genetic, viral and demographic associations. Hepatology (2012) 1.30
Comparison of hepatitis C viral loads in patients with or without human immunodeficiency virus. Clin Diagn Lab Immunol (2001) 1.24
The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985. Gut (2000) 1.17
HCV and HIV co-infection: mechanisms and management. Nat Rev Gastroenterol Hepatol (2014) 1.16
Hepatitis C and HIV-1 coinfection. Gut (2002) 1.12
Human immunodeficiency virus seroconversion and evolution of the hepatitis C virus quasispecies. J Virol (2001) 1.08
Hepatitis C and haemophilia. BMJ (1995) 1.00
Factors affecting serum concentrations of hepatitis C virus (HCV) RNA in HCV genotype 1-infected patients with chronic hepatitis. J Clin Microbiol (2007) 1.00
Liver transplantation for haemophiliacs with hepatitis C cirrhosis. Gut (1996) 0.96
HIV and co-infections. Immunol Rev (2013) 0.92
Influence of hepatitis C virus infection on the mortality of antiretroviral-treated patients with HIV disease. Eur J Clin Microbiol Infect Dis (1998) 0.89
Outcome of orthotopic liver transplantation in patients with haemophilia. Gut (1998) 0.89
Liver histopathology in patients with concurrent chronic hepatitis C and HIV infection. Virchows Arch (1997) 0.88
The Tat protein of human immunodeficiency virus-1 enhances hepatitis C virus replication through interferon gamma-inducible protein-10. BMC Immunol (2012) 0.88
Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups. Dig Dis Sci (1996) 0.87
CD4+ T-Cell-Dependent Reduction in Hepatitis C Virus-Specific Neutralizing Antibody Responses After Coinfection With Human Immunodeficiency Virus. J Infect Dis (2015) 0.83
Management complexities of HIV/hepatitis C virus coinfection in the twenty-first century. Clin Liver Dis (2008) 0.83
Never injected, but hepatitis C virus-infected: a study among self-declared never-injecting drug users from the Amsterdam Cohort Studies. J Viral Hepat (2009) 0.82
Comparison of hepatitis C viral loads in patients with or without coinfection with different genotypes. Clin Diagn Lab Immunol (2004) 0.82
Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users. World J Gastroenterol (2007) 0.81
Hepatitis C in human immunodeficiency virus co-infected individuals: Is this still a "special population"? World J Hepatol (2015) 0.81
Chronic hepatitis C virus infection and increases in viral load in a prospective cohort of young, HIV-uninfected injection drug users. Drug Alcohol Depend (2011) 0.80
Plasma Hepatitis C Virus Viral Load Among Hepatitis C Virus Mono-Infected and HCV/HIV Co-Infected Individuals in Yunnan Province,China. Hepat Mon (2012) 0.80
Management of Hepatitis C in HIV-infected Patients. Curr Infect Dis Rep (2005) 0.80
Hepatitis C Virus and HIV Type 1 Co-Infection. Infect Dis Rep (2013) 0.79
CD127 expression, exhaustion status and antigen specific proliferation predict sustained virologic response to IFN in HCV/HIV co-infected individuals. PLoS One (2014) 0.78
Anti-HCV antibody among newly diagnosed HIV patients in Ughelli, a suburban area of Delta State Nigeria. Afr Health Sci (2015) 0.77
No significant changes in levels of hepatitis C virus (HCV) RNA by competitive polymerase chain reaction in blood samples from patients with chronic HCV infection. Dig Dis Sci (1997) 0.77
Influence of Hepatitis C Virus Sustained Virological Response on Immunosuppressive Tryptophan Catabolism in ART-Treated HIV/HCV Coinfected Patients. J Acquir Immune Defic Syndr (2016) 0.77
TRAIL dependent fratricidal killing of gp120 primed hepatocytes by HCV core expressing hepatocytes. PLoS One (2011) 0.76
Correlates of high hepatitis C virus RNA load in a cohort of HIV-negative and HIV-positive individuals with haemophilia. J Viral Hepat (2011) 0.76
Dissociation of serum and liver hepatitis C virus RNA levels in patients coinfected with human immunodeficiency virus and treated with antiretroviral drugs. J Clin Microbiol (2004) 0.76
Reciprocal interaction of human immunodeficiency virus and hepatitis C virus infections. Clin Diagn Lab Immunol (2001) 0.76
Differential regulation of cytotoxicity pathway discriminating between HIV, HCV mono- and co-infection identified by transcriptome profiling of PBMCs. Virol J (2015) 0.75
Antiretroviral therapy, interferon sensitivity, and virologic setpoint in human immunodeficiency virus/hepatitis C virus coinfected patients. Hepatology (2014) 0.75
Analytical and biological variables influencing quantitative hepatitis C virus (HCV) measurement in HIV-HCV coinfection. Can J Gastroenterol (2006) 0.75
Statin drugs decrease progression to cirrhosis in HIV/HCV co-infected individuals. AIDS (2016) 0.75
Outcome of liver transplantation for haemophilia. HPB (Oxford) (2010) 0.75
Characteristics of hepatitis C virus infection in HIV-infected people. Can J Infect Dis (2001) 0.75
HIV Vpr protein upregulates microRNA-122 expression and stimulates hepatitis C virus replication. J Gen Virol (2015) 0.75
Hepatitis C infection after blood product transfusion. Arch Dis Child (1996) 0.75
Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol (1999) 14.07
Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med (1996) 10.49
HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science (1999) 8.11
Association of cancer with AIDS-related immunosuppression in adults. JAMA (2001) 6.80
Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease. N Engl J Med (1991) 6.09
Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N Engl J Med (1995) 5.98
Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med (2001) 4.98
Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men. Lancet (1984) 4.68
Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications. JAMA (1985) 4.26
Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst (2000) 3.77
Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science (1998) 3.60
Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA (1996) 3.50
Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members. Science (1986) 3.31
Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. Ann Intern Med (1990) 2.99
Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml. J Infect Dis (2001) 2.95
NIH conference. Hepatocellular carcinoma. Ann Intern Med (1988) 2.94
Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group. Ann Intern Med (1995) 2.61
Natural history of HIV-1 cell-free viremia. JAMA (1995) 2.58
Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA (1998) 2.55
Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1995) 2.49
Racial differences in HLA class II associations with hepatitis C virus outcomes. J Infect Dis (2001) 2.47
Genetic polymorphism in CX3CR1 and risk of HIV disease. Science (2000) 2.38
Therapy may explain recent deficits in AIDS incidence. J Acquir Immune Defic Syndr (1990) 2.35
Spontaneous bacterial peritonitis caused by infection with Listeria monocytogenes: a case report and review of the literature. Am J Gastroenterol (1998) 2.35
Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J Virol (1995) 2.34
Genotypic analysis of hepatitis C virus in American patients. Hepatology (1994) 2.33
Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc Natl Acad Sci U S A (2000) 2.24
Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. Ann Intern Med (1987) 2.24
Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer (1989) 2.24
Long-term seropositivity for human T-lymphotropic virus type III in homosexual men without the acquired immunodeficiency syndrome: development of immunologic and clinical abnormalities. A longitudinal study. Ann Intern Med (1986) 2.06
Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. Ann Intern Med (2001) 2.05
Absence of hepatitis C viral RNA from saliva and semen of patients with chronic hepatitis C. Gastroenterology (1992) 1.99
Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy. J Infect Dis (1982) 1.98
Risk of human immunodeficiency virus (HIV-1) infection among laboratory workers. Science (1988) 1.97
Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatol (2000) 1.92
Long-term remission of chronic hepatitis B after alpha-interferon therapy. Ann Intern Med (1991) 1.92
Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Ann Intern Med (1991) 1.91
Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndrome. J Natl Cancer Inst (1991) 1.91
Hepatitis C viral RNA in serum of patients with chronic non-A, non-B hepatitis: detection by the polymerase chain reaction using multiple primer sets. Hepatology (1991) 1.82
Risk of cancer in children with AIDS. AIDS-Cancer Match Registry Study Group. JAMA (2000) 1.79
Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C. J Clin Invest (1991) 1.77
Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study. J Acquir Immune Defic Syndr (1993) 1.63
Preclinical evaluation of AMPLICOR hepatitis C virus test for detection of hepatitis C virus RNA. J Clin Microbiol (1995) 1.63
What is safe sex? Suggested standards linked to testing for human immunodeficiency virus. N Engl J Med (1987) 1.63
Population-based monitoring of an urban HIV/AIDS epidemic. Magnitude and trends in the District of Columbia. JAMA (1992) 1.62
Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet (1996) 1.62
Consistent associations of HLA class I and II and transporter gene products with progression of human immunodeficiency virus type 1 infection in homosexual men. J Infect Dis (1999) 1.60
Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus. JAMA (1987) 1.60
Recurrence of hepatitis C virus infection after orthotopic liver transplantation. Hepatology (1991) 1.57
Amyl nitrite may alter T lymphocytes in homosexual men. Lancet (1982) 1.54
Incidence of Kaposi's sarcoma and mycosis fungoides in the United States including Puerto Rico, 1973-81. J Natl Cancer Inst (1984) 1.54
Is vaccination against hepatitis B infection indicated in patients waiting for or after orthotopic liver transplantation? Liver Transpl Surg (1998) 1.54
Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine. Clin Infect Dis (1998) 1.51
Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology (1995) 1.51
Development and early natural history of HTLV-III antibodies in persons with hemophilia. JAMA (1985) 1.50
Histological evaluation of iron in liver biopsies: relationship to HFE mutations. Am J Gastroenterol (2000) 1.50
Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C. Hepatology (2001) 1.49
Epidemiology of squamous cell conjunctival cancer. Cancer Epidemiol Biomarkers Prev (1997) 1.47
Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors. Transfusion (2003) 1.47
The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. Hepatology (1991) 1.45
HTLV-I/II seroprevalence and HIV/HTLV coinfection among U.S. intravenous drug users. J Acquir Immune Defic Syndr (1991) 1.45
Clinical utility of HIV-IgA immunoblot assay in the early diagnosis of perinatal HIV infection. JAMA (1991) 1.44
Viral hepatitis and hepatocellular carcinoma. Gastroenterol Clin North Am (1994) 1.42
Acid-labile alpha interferon. A possible preclinical marker for the acquired immunodeficiency syndrome in hemophilia. N Engl J Med (1983) 1.41
Oligoclonal immunoglobulin bands in serum in association with chronic viral hepatitis. Am J Gastroenterol (1990) 1.41
Determination of T-lymphocyte subsets on site in rural Tanzania: results in HIV-1 infected and non-infected individuals. Int J STD AIDS (1996) 1.39
Seizures during alpha interferon therapy. J Hepatol (1996) 1.39
Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B. J Hepatol (2001) 1.38
Simian virus 40 and pleural mesothelioma in humans. Cancer Epidemiol Biomarkers Prev (1996) 1.38
Decreased helper T lymphocytes in homosexual men. I. Sexual contact in high-incidence areas for the acquired immunodeficiency syndrome. Am J Epidemiol (1985) 1.37
Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med (1991) 1.36
Immunosuppression in pregnant women infected with human immunodeficiency virus. Am J Obstet Gynecol (1989) 1.36
Characterization of high-risk HIV-1 seronegative hemophiliacs. Clin Immunol (2001) 1.35
Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology (1989) 1.33
Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: rates, risk factors, and relationship to Kaposi's sarcoma. J Infect Dis (1999) 1.31
HTLV-III infection among health care workers. Association with needle-stick injuries. JAMA (1985) 1.31
Reduced risk of AIDS lymphoma in individuals heterozygous for the CCR5-delta32 mutation. Cancer Res (1999) 1.30
A pilot study of ribavirin therapy for chronic hepatitis C. Hepatology (1992) 1.30
Evaluation of branched DNA signal amplification for the detection of hepatitis C virus RNA. J Viral Hepat (1995) 1.28
Identifying human herpesvirus 8 infection: performance characteristics of serologic assays. J Acquir Immune Defic Syndr (2000) 1.28
Risk of AIDS after herpes zoster. Lancet (1987) 1.28
Accelerated loss of antibody to hepatitis B surface antigen among immunodeficient homosexual men infected with HIV. N Engl J Med (1987) 1.27
Prevalence and changes in hepatitis C virus genotypes among multitransfused persons with hemophilia. The Multicenter Hemophilia Cohort Study. J Infect Dis (1999) 1.27
Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon. Hepatology (1992) 1.26
Censoring in an epidemic with an application to hemophilia-associated AIDS. Biometrics (1989) 1.26
Seminal fluid excretion of cytomegalovirus related to immunosuppression in homosexual men. Br Med J (Clin Res Ed) (1983) 1.26
Radiogenic male breast cancer with in vitro sensitivity to ionizing radiation and bleomycin. Cancer Invest (1983) 1.24
Kaposi's sarcoma herpes virus and Kaposi's sarcoma in the elderly populations of 3 Mediterranean islands. Int J Cancer (2001) 1.24
Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from The Gambia. J Natl Cancer Inst (2000) 1.23
Geographic distribution and genetic variability of hepatitis delta virus genotype I. Virology (1997) 1.22
Prospective multicenter clinical evaluation of AMPLICOR and COBAS AMPLICOR hepatitis C virus tests. J Clin Microbiol (2001) 1.22
Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa. Gastroenterology (1992) 1.22
Cryoglobulinemia associated with Purtscher-like retinopathy. Am J Ophthalmol (2001) 1.21
Single nucleotide polymorphisms and haplotypes in the IL10 region associated with HCV clearance. Genes Immun (2005) 1.21
Exposure factors for HIV-1 infection among heterosexual drug abusers in New Jersey treatment programs. AIDS Res Hum Retroviruses (1990) 1.21
Antibodies reactive with human T cell leukemia viruses in the serum of hemophiliacs receiving factor VIII concentrate. Blood (1985) 1.21